Engineering enzymes with potential against ALS and Parkinson's disease‎

In an advance that could one day lead to new treatments for neurodegenerative diseases, Meredith Jackrel, an associate professor of chemistry in Arts & Sciences at Washington University in St. Louis, and her team have developed a method to rapidly produce and screen a class of disaggregase enzymes that can break down the misfolded proteins associated with ALS and Parkinson's disease.